• PDF / 169,196 Bytes
• 1 Pages / 595.245 x 841.846 pts (A4) Page_size
• 29 Downloads / 237 Views

DOWNLOAD

REPORT

---

1 S

Acute pulmonary oedema: case report In a retrospective study involving 946 patients treated across various haematological centers in Italy between 1999 and 2015, a 92-year-old woman* was described, who developed acute pulmonary oedema during treatment with doxorubicin-liposomal for lymphoma. The woman with lymphoma, started receiving treatment with infusion doxorubicin-liposomal [Myocet; dosage not stated], cyclophosphamide, vincristine, prednisone and rituximab (R-COMP therapy). However, she developed doxorubicinliposomal therapy related acute pulmonary oedema [duration of treatment to reaction onset and outcome not stated]. * Identifying patient details (age and sex) have been obtained through direct communication with the author. Rigacci L, et al. Nonpeghylated liposomal doxorubicin combination regimen (R-COMP) for the treatment of lymphoma patients with advanced age or cardiac comorbidity. 803517226 Hematological Oncology 38: 478-486, No. 4, Oct 2020. Available from: URL: http://doi.org/10.1002/hon.2764

0114-9954/20/1832-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

Reactions 28 Nov 2020 No. 1832